SCHEMBL16232174

SCHEMBL16232174

O=C(Cl)C1(S(=O)(=O)c2ccc(F)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
MMP3 P08254 1/20 0.50
MMP10 P09238 1/20 0.50
MMP1 P03956 3/20 0.43
MMP9 P14780 3/20 0.43
MMP13 P45452 3/20 0.43
ADAM17 P78536 1/20 0.43
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RORC P51449 4/20 0.40
NR1I2 O75469 3/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP2 P08253 1/20 0.40
MMP8 P22894 1/20 0.40
PSEN1 P49768 2/20 0.40
PSEN2 P49810 2/20 0.40
APH1B Q8WW43 2/20 0.40
NCSTN Q92542 2/20 0.40
APH1A Q96BI3 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13822796 0.84 ALDH1A1 (0.56) ALDH1A1MMP3MMP10MMP1MMP9
SCHEMBL13896735 0.82 ALDH1A1 (0.58) ALDH1A1MMP3MMP10MMP1MMP9
SCHEMBL25316944 0.78 PKM (0.61) ALDH1A1MMP3MMP10MMP1MMP9
SCHEMBL16880400 0.77 PHGDH (0.51) ALDH1A1MMP3MMP10RORCNR1I2
SCHEMBL6223029 0.73 PHGDH (0.53) ALDH1A1MMP3MMP1MMP9MMP13
SCHEMBL28841537 0.73 ALDH1A1 (0.47) ALDH1A1MMP3MMP10MMP2
SCHEMBL27091895 0.71 ALDH1A1 (0.45) ALDH1A1MMP3MMP10MMP1MMP9
SCHEMBL28111260 0.70 RORC (0.49) ALDH1A1MMP1MMP9MMP13RORC
SCHEMBL5919554 0.70 MMP13 (0.67) MMP3MMP1MMP9MMP13ADAM17
SCHEMBL351726 0.69 EEF2K (0.58) ALDH1A1HPGDNPSR1PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150299184-A1 Amine Derivatives as Potassium Channel Blockers BIONOMICS LIMITED (AU) 2015-10-22 US disclosed
US-20150299184-A1 Amine Derivatives as Potassium Channel Blockers BIONOMICS LIMITED (AU) 2015-10-22 US disclosed
US-20140336198-A1 Amine Derivatives as Potassium Channel Blockers MERCK PATENT GMBH (DE) 2014-11-13 US disclosed
US-20140336198-A1 Amine Derivatives as Potassium Channel Blockers MERCK PATENT GMBH (DE) 2014-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336198-A1 Amine Derivatives as Potassium Channel Blockers KCNA3, KCNH3, KCNK3 ALDH1A1 3267/4885MMP3 3311/4885MMP10 4159/4885
US-20150299184-A1 Amine Derivatives as Potassium Channel Blockers KCNA3, KCNH3, KCNK3 ALDH1A1 3267/4885MMP3 3311/4885MMP10 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.